Total Payments
$3,381
2024 Payments
$337.82
Companies
24
Transactions
173
Medicare Patients
6,958
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$3,381 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,381 | 173 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,107 | 72 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $884.86 | 38 | $0 (2023) |
| Teleflex LLC | $162.67 | 2 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $150.70 | 9 | $0 (2020) |
| Mylan Specialty L.P. | $144.41 | 8 | $0 (2024) |
| Advanced Respiratory, Inc | $134.45 | 9 | $0 (2021) |
| Edwards Lifesciences Corporation | $116.58 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $115.48 | 8 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $84.11 | 4 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $64.43 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $337.82 | 10 | Teleflex LLC ($162.67) |
| 2023 | $94.93 | 4 | GlaxoSmithKline, LLC. ($66.20) |
| 2022 | $236.86 | 11 | GlaxoSmithKline, LLC. ($85.89) |
| 2021 | $510.33 | 24 | GlaxoSmithKline, LLC. ($190.84) |
| 2020 | $509.28 | 26 | Boehringer Ingelheim Pharmaceuticals, Inc. ($201.84) |
| 2019 | $626.21 | 34 | GlaxoSmithKline, LLC. ($127.69) |
| 2018 | $583.54 | 33 | Boehringer Ingelheim Pharmaceuticals, Inc. ($159.05) |
| 2017 | $482.47 | 31 | GlaxoSmithKline, LLC. ($234.97) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: RESPIRATORY | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: RESPIRATORY | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/27/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $147.04 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 01/29/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 01/09/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $25.58 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 11/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: RESPIRATORY | ||||||
| 02/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: RESPIRATORY | ||||||
| 01/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: RESPIRATORY | ||||||
| 11/03/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: Infections and Infectious Diseases | ||||||
| 09/06/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), NUCALA | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: RESPIRATORY | ||||||
| 05/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: RESPIRATORY | ||||||
| 04/27/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2022 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/15/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: RESPIRATORY | ||||||
| 02/14/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: RESPIRATORY | ||||||
| 01/27/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $27.82 | General |
| Category: RESPIRATORY | ||||||
| 01/19/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,423 | 3,342 | $488,594 | $261,763 |
| 2022 | 5 | 1,624 | 4,338 | $620,836 | $333,232 |
| 2021 | 6 | 1,813 | 4,174 | $597,449 | $332,095 |
| 2020 | 9 | 2,098 | 4,682 | $715,301 | $375,573 |
Total Patients
6,958
Total Services
16,536
Medicare Billing
$1.3M
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 429 | 2,040 | $228,288 | $134,261 | 58.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 419 | 541 | $168,159 | $75,053 | 44.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 438 | 574 | $63,957 | $38,753 | 60.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 135 | $15,660 | $8,045 | 51.4% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 37 | 37 | $9,531 | $4,019 | 42.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $3,000 | $1,633 | 54.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 532 | 2,846 | $318,752 | $172,102 | 54.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 484 | 639 | $199,368 | $105,547 | 52.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 478 | 634 | $71,642 | $38,805 | 54.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 95 | 184 | $21,344 | $11,876 | 55.6% |
| 99235 | Hospital observation or inpatient care admitted and discharged on the same day for moderate severity problem, typically 50 minutes | Facility | 2022 | 35 | 35 | $9,730 | $4,901 | 50.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 651 | 2,717 | $304,304 | $167,828 | 55.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 514 | 624 | $194,688 | $107,238 | 55.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 523 | 614 | $69,382 | $38,474 | 55.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 177 | $20,588 | $13,199 | 64.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 29 | 29 | $7,018 | $4,541 | 64.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 13 | 13 | $1,469 | $816.40 | 55.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 654 | 2,799 | $321,780 | $175,095 | 54.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 570 | 736 | $239,044 | $123,759 | 51.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 570 | 717 | $85,977 | $45,815 | 53.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 170 | $34,850 | $14,809 | 42.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 81 | 111 | $15,540 | $5,397 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 38 | 38 | $8,360 | $4,969 | 59.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 41 | 43 | $3,225 | $2,610 | 80.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 25 | 25 | $4,375 | $2,305 | 52.7% |
About Dr. Robert Siew, M.D
Dr. Robert Siew, M.D is a Internal Medicine healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578539516.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Siew, M.D has received a total of $3,381 in payments from pharmaceutical and medical device companies, with $337.82 received in 2024. These payments were reported across 173 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,381).
As a Medicare-enrolled provider, Siew has provided services to 6,958 Medicare beneficiaries, totaling 16,536 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pasadena, CA
- Active Since 02/28/2006
- Last Updated 10/13/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578539516
Products in Payments
- TRELEGY ELLIPTA (Drug) $601.72
- STIOLTO RESPIMAT (Drug) $506.09
- OFEV (Drug) $207.55
- ANORO ELLIPTA (Drug) $183.47
- ANORO (Drug) $167.79
- UROLIFT (Device) $162.67
- BREO (Drug) $153.56
- ZERBAXA (Drug) $150.70
- STIOLTO (Drug) $145.14
- DUPIXENT (Biological) $132.52
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $116.58
- The Vest System Model 105 Home Care (Device) $95.79
- Yupelri (Drug) $85.21
- SYMBICORT (Drug) $80.69
- OPSUMIT MACITENTAN (Drug) $64.43
- MRI Ready Leads (Device) $62.50
- YUPELRI (Drug) $59.20
- Fetroja (Drug) $55.21
- XARELTO (Drug) $41.66
- BREZTRI (Drug) $34.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pasadena
Dr. Yuan Yuan, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $523,801
Internal Medicine $523,801
Christopher Dagher, M.d, M.D
Internal Medicine — Payments: $103,615
Internal Medicine $103,615
Peter Haddad, M.d, M.D
Internal Medicine — Payments: $87,600
Internal Medicine $87,600
Dr. Andrew Williams, M.d, M.D
Internal Medicine — Payments: $85,273
Internal Medicine $85,273
Joseph Dellinger, Md, MD
Internal Medicine — Payments: $77,175
Internal Medicine $77,175
Dr. Helen Moon, M.d, M.D
Internal Medicine — Payments: $61,882
Internal Medicine $61,882